Abstract
The prevalence of neurodegenerative diseases such as Parkinson disease (PD) will increase substantially, due to the aging of the population and improved treatments leading to better disease-related outcomes. Dementia is the most common nonmotor symptom in PD, and most patients with PD will have cognitive dysfunction and cognitive decline in the course of their disease. The development of cognitive dysfunction in PD greatly limits the ability to participate in activities of daily living and can be a tipping point for nursing home placement or major caregiver stress. Understanding the different causes of dementia and how to reduce the incidence and impact of secondary cognitive dysfunction in PD are necessary skills for primary care physicians and neurologists. In this review, we discuss the clinical epidemiology of dementia in PD with an emphasis on preventable cognitive dysfunction, present tools for outpatient evaluation of cognitive dysfunction, and describe current pharmacological treatments for dementia in PD.
Original language | English (US) |
---|---|
Pages (from-to) | 585-594 |
Number of pages | 10 |
Journal | American Journal of Alzheimer's Disease and Other Dementias |
Volume | 31 |
Issue number | 7 |
DOIs | |
State | Published - Nov 1 2016 |
Externally published | Yes |
Keywords
- Parkinson disease
- Parkinson disease with dementia
- dementia
- epidemiology
- mild cognitive impairment
ASJC Scopus subject areas
- General Neuroscience
- Clinical Psychology
- Geriatrics and Gerontology
- Psychiatry and Mental health